CIK 0001870404 · <br>Emerging growth company
CERO THERAPEUTICS HOLDINGS, INC.
Sign in to watch- Tickers
- CERO CEROW
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 871088814
- Phone
- 650-407-2376
- Business address
- 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CERO THERAPEUTICS HOLDINGS, INC., PHOENIX BIOTECH ACQUISITION CORP.
Securities
- CERO Common stock OTC
- CEROW Common stock OTC
- PRE 14A Proxy Proxy Statement (Preliminary)
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Other acquisition 10% owner acquired 36,733 shares (other)
- 4 Other acquisition CEO and Secretary acquired 36,733 shares (other)
- 4 Derivatives Options or other derivatives
Page 21 of 23 · 445 filings